Wejde J - Search Results

1

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Brodin BA, Wennerberg K, Lidbrink E, Brosjö O, Potdar S, Wilson JN, Ma L, Moens LN, Hesla A, Porovic E, Bernhardsson E, Papakonstantinou A, Bauer H, Tsagkozis P, von Sivers K, Wejde J, Östling P, Kallioniemi O, Stragliotto CL. Brodin BA, et al. Among authors: wejde j. Br J Cancer. 2019 Feb;120(4):435-443. doi: 10.1038/s41416-018-0359-4. Epub 2019 Feb 12. Br J Cancer. 2019. PMID: 30745580 Free PMC article.

2

Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.

Girnita L, Girnita A, Brodin B, Xie Y, Nilsson G, Dricu A, Lundeberg J, Wejde J, Bartolazzi A, Wiman KG, Larsson O. Girnita L, et al. Among authors: wejde j. Cancer Res. 2000 Sep 15;60(18):5278-83. Cancer Res. 2000. PMID: 11016658

3

Pre-operative radiotherapy in soft tissue tumors. Assessment of response by static post-contrast MR imaging compared to histopathology.

Einarsdottir H, Wejde J, Bauer HC. Einarsdottir H, et al. Among authors: wejde j. Acta Radiol. 2001 Jan;42(1):1-5. Acta Radiol. 2001. PMID: 11167322

4

A highly aggressive primitive mesenchymal tumor with a translocation (1;19)(q12;q13.2).

Lui W, Wejde J, Tani E, Brosjö O, Kytölä S, Larsson C. Lui W, et al. Among authors: wejde j. Cancer Genet Cytogenet. 2001 Jun;127(2):128-33. doi: 10.1016/s0165-4608(00)00437-4. Cancer Genet Cytogenet. 2001. PMID: 11425451

5

Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma.

Storlazzi CT, Mertens F, Nascimento A, Isaksson M, Wejde J, Brosjo O, Mandahl N, Panagopoulos I. Storlazzi CT, et al. Among authors: wejde j. Hum Mol Genet. 2003 Sep 15;12(18):2349-58. doi: 10.1093/hmg/ddg237. Epub 2003 Jul 22. Hum Mol Genet. 2003. PMID: 12915480

6

Diffusion-weighted MRI of soft tissue tumours.

Einarsdóttir H, Karlsson M, Wejde J, Bauer HC. Einarsdóttir H, et al. Among authors: wejde j. Eur Radiol. 2004 Jun;14(6):959-63. doi: 10.1007/s00330-004-2237-0. Epub 2004 Feb 6. Eur Radiol. 2004. PMID: 14767604

7

The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.

Panagopoulos I, Storlazzi CT, Fletcher CD, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjö O, Rydholm A, Isaksson M, Mandahl N, Mertens F. Panagopoulos I, et al. Among authors: wejde j. Genes Chromosomes Cancer. 2004 Jul;40(3):218-28. doi: 10.1002/gcc.20037. Genes Chromosomes Cancer. 2004. PMID: 15139001

8

A novel case of synovial sarcoma of the kidney: impact of SS18/SSX analysis of renal hemangiopericytoma-like tumors.

Törnkvist M, Wejde J, Ahlén J, Brodin B, Larsson O. Törnkvist M, et al. Among authors: wejde j. Diagn Mol Pathol. 2004 Mar;13(1):47-51. doi: 10.1097/00019606-200403000-00008. Diagn Mol Pathol. 2004. PMID: 15163009

9

Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.

Ahlén J, Wejde J, Brosjö O, von Rosen A, Weng WH, Girnita L, Larsson O, Larsson C. Ahlén J, et al. Among authors: wejde j. Clin Cancer Res. 2005 Jan 1;11(1):206-16. Clin Cancer Res. 2005. PMID: 15671548

10

Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling.

Maruwge W, D'Arcy P, Folin A, Brnjic S, Wejde J, Davis A, Erlandsson F, Bergh J, Brodin B. Maruwge W, et al. Among authors: wejde j. Onco Targets Ther. 2008 Nov 1;1:67-78. doi: 10.2147/ott.s3833. Onco Targets Ther. 2008. PMID: 21127754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page